newsfilter
← Latest News
PR Newswire·

NRx Pharmaceuticals Files Counterclaim Against its Former Collaboration Partner, Relief Therapeutics

RADNOR, Pa., Jan. 12, 2022 /PRNewswire/ -- NRx Pharmaceuticals (NASDAQ:NRXP) filed a lawsuit on Monday against Relief Therapeutics ((SIX: RLF, OTCQB:RLFTF, RLFTY)), its former collaboration partner, in New York State Supreme Court. https://iapps.courts.